Newsroom | 7864 results

DENVER--(BUSINESS WIRE)--Transverse Medical Announces Completion of First Series of Patients in Feasibility Clinical Study - Victorian Heart Hospital, Melbourne, Australia....

SAN DIEGO--(BUSINESS WIRE)--Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, will showcase its transformative vMap technology at Heart Rhythm 2025, taking place April 25–27 in San Diego. Through live demonstrations at adjacent booths (#1523 and #1622), scientific abstract presentations, and a highly anticipated Rhythm Theater session featuring leading electrophysiologists, Vektor will offer attendees a firsthand look at how vMap is being integrated into clini...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its commercial and development portfolio will be presented at the American Thoracic Society (ATS) International Conference in San Francisco on May 16-21, 2025. At ATS, United Therapeutics is sponsoring several events including the Respiratory Innovation Summit and the ATS Research Program Benefit Networking...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases, today announced that the company granted inducement equity awards covering an aggregate of 156,650 shares of its common stock to 19 newly hired employees, consisting of inducement stock options to purchase an aggregate of 89,515 shares of common stock and...

CAIRO--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly improved long-term outcomes compared to those receiving non-RESILIA tissue bioprosthetic valves. For more than 65 years, Edwards has been the leader in heart valve innovations. To create a more durable heart valve, Edwards developed the RESILIA tissue technology more than two d...

PRINCETON, N.J.--(BUSINESS WIRE)--U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications...

CHICAGO--(BUSINESS WIRE)--A new independent study by researchers at Aon has found significant cost reductions for employers offering Hello Heart's digital heart health program....

PONTE VEDRA, Fla.--(BUSINESS WIRE)--Cadrenal Therapeutics to present at inaugural Centri Capital Conference at Nasdaq on April 22, 2025....

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has received Breakthrough Device designation from the U.S. Food and Drug Administration (“FDA”) for its vCLASTM Cryoablation System for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (“VT”) in patients with ischemic or non...

PARIS--(BUSINESS WIRE)--Artedrone, Truffle Capital’s medtech portfolio company developing an autonomous microrobotic solution for mechanical thrombectomy (MT) procedures to treat patients suffering from a stroke, announced the successful completion of a set of various in vitro and animal studies demonstrating the ability of the company’s SASHA microrobotic solution to autonomously perform mechanical thrombectomy. Results from the study are being submitted for publication in to a research journa...